PYC Therapeutics Ltd
ASX:PYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
|
Odakyu Electric Railway Co Ltd
OTC:ODERF
|
JP |
|
P
|
Partners Group Holding AG
XMUN:P2H
|
CH |
|
P
|
Principal Financial Group Inc
XMUN:PG4
|
US |
|
CD Projekt SA
F:7CD
|
PL |
|
Omda AS
OSE:OMDA
|
NO |
|
Melia Hotels International SA
MAD:MEL
|
ES |
Intrinsic Value
Is PYC undervalued or overvalued?
See the intrinsic value estimate for PYC Therapeutics Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PYC looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with PYC’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What PYC Therapeutics Does
PYC Therapeutics is a biotechnology company that develops RNA-based medicines for inherited diseases. Its core idea is to design short RNA molecules that help cells make the right protein when a gene is not working properly. The company is focused on rare disorders with clear genetic causes, where fixing the underlying RNA problem may address the disease itself rather than just the symptoms.
- Headquarters
- Australia AU
- Employees
- 5
- IPO date
- Mar 30, 2005
Earnings Waterfall
PYC Therapeutics Ltd
The intrinsic value for PYC Therapeutics Ltd (PYC) under the Base Case is hidden AUD.
Compared with the current market price of 1.98 AUD, the stock appears hidden.